High dose Losartan and ACE gene polymorphism in IgA nephritis. - Wikidata - awgldk - TriplyDB

High dose Losartan and ACE gene polymorphism in IgA nephritis.

High dose Losartan and ACE gene polymorphism in IgA nephritis.

http://www.wikidata.org/entity/Q37223733

about

A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.

P2860

Q53107647-CAD1377E-DE2B-4F9F-AF4F-C214133562FC

P2860

High dose Losartan and ACE gene polymorphism in IgA nephritis.

http://www.wikidata.org/entity/Q37223733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@en

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@nl

type

label

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@en

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@nl

prefLabel

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@en

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@nl

P1433

Q37223733-D6CF0CCD-53E5-4B19-A87F-4A4783862EB1

P1476

Q37223733-CF3D32B6-8642-4D95-AE61-E01E878426BE

P2093

Q37223733-09632DD4-40AC-412C-8468-01ADE0A25880

Q37223733-0CA08D32-DDD0-4F93-AF24-90742FAFF00A

Q37223733-1B17B100-64ED-4BCE-92DC-872F5928C151

Q37223733-2B444C7C-0D64-4204-930D-1F0416EB5AB6

Q37223733-348E70E1-FAAD-40E3-9092-6334D6B76777

Q37223733-38E2F9CA-DEF5-4D8D-A105-9BEDA9189E22

Q37223733-52CAC888-CDBF-434F-808C-76623462A6F0

Q37223733-5988ABC2-DC53-4248-8C1E-349D7F87B2C4

Q37223733-64F40A7C-7B2A-47E0-ADAD-7DA64B322FD1

Q37223733-77C7E333-03F7-48ED-90DD-E0FC25AB3D3E

P2860

Q37223733-03D4A541-246F-4998-8CC7-E8A88933D0EF

Q37223733-11A15006-3101-4977-AB6F-1E0A140B93A7

Q37223733-57815EC5-B6F7-4CD5-9C1C-9BA17D06B196

Q37223733-599A4DB6-BA7F-4A4C-A38B-0A12A505EE00

Q37223733-660A87C9-3D7C-4984-BE2A-2423CED673C2

Q37223733-68683A93-8A57-4814-8158-D3C74A8033C9

Q37223733-858A534B-623B-4176-A9B8-D4F140D3950C

Q37223733-A469DE22-3A49-424F-B613-1040B1B04ADF

Q37223733-DAB56DF3-4CA5-419C-896D-2A5338EFD7AB

Q37223733-F2F726F2-0842-4B9F-9B6F-FC9A61141FFE

P304

Q37223733-2EE5B5B5-23C6-4AB5-84D2-9B66CAF32412

P31

Q37223733-86433052-55C3-4B69-9399-BE880E292EA9

P356

Q37223733-71C8553B-1124-463F-A3B1-46C4EA6849E0

P433

Q37223733-7C67BD8B-068E-45CC-82F8-34F6E56CF58B

P478

Q37223733-97FFAC29-8C43-4091-B499-26A227ED8E2F

P577

Q37223733-348591E7-4104-4C60-98BD-BF3938FEC1BF

P5875

Q37223733-7F58AB6E-2CBF-4A51-9EAB-EBAA441E775A

P698

Q37223733-2E877205-F94C-4404-9FF2-F9AEE4746097

P932

Q37223733-D523510B-37C4-4662-89C7-6959436F9179

P356

S11568-009-9030-8

P1433

Genomic medicine

P1476

High dose Losartan and ACE gene polymorphism in IgA nephritis.

@en

P2093

A Vathsala

http://www.w3.org/2001/XMLSchema#string

Cheng-Hong Lim

http://www.w3.org/2001/XMLSchema#string

Choong-Meng Chan

http://www.w3.org/2001/XMLSchema#string

Chorh-Chuan Tan

http://www.w3.org/2001/XMLSchema#string

Evan J C Lee

http://www.w3.org/2001/XMLSchema#string

Gilbert S C Chiang

http://www.w3.org/2001/XMLSchema#string

Grace S L Lee

http://www.w3.org/2001/XMLSchema#string

H B Tan

http://www.w3.org/2001/XMLSchema#string

Han-Kim Tan

http://www.w3.org/2001/XMLSchema#string

Hui-Lin Choong

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.

ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study.

ATRA therapy restores normal renal function and renal reserve and prevents renal failure.

Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria.

Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.

Low-responders to angiotensin II receptor blockers and genetic polymorphism in angiotensin-converting enzyme.

P304

83-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11568-009-9030-8

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24232595

http://www.w3.org/2001/XMLSchema#string

P698

19319668

http://www.w3.org/2001/XMLSchema#string

P932

2694861

http://www.w3.org/2001/XMLSchema#string